Within IMI 2-funded projects, ‘Deliverables’ are “outputs that must be produced at a given moment” during the project. This includes, for example, detailed information on the scientific progress of a specific task, a research manuscript, a special report, a technical diagram, a brochure, a software, or another important “building block”. As soon as such a deliverable has been completed, a detailed deliverable report is required to be submitted to and checked by the Innovative Medicines Initiative 2 Joint Undertaking (IMI 2 JU).
The following public EQIPD deliverable reports are public:
Summary report of third research period (Jan 2019 – Dec 2019)
WP1 – Project management and oversight
Deliverable Report D1.1 – First press release
Deliverable Report 1.5 – First quarterly electronic bulletin
WP4 – Prospective cross-site validation of guiding principles in specific assay
Deliverable Report D4.1 – Obtain ethical approval for cross-site validation studies and ring testing
WP5 – New quality management system in emerging and classical technologies to improve preclinical robustness
Deliverable Report D5.3 – Quality reporting module in research
software (prototype)
WP7 – E-learning course on scientific quality
Deliverable Report D7.1 – Evaluation of Existing Training Modules
WP8 – Data management
Deliverable Report D8.1 – Data Inclusion Protocol
Deliverable Report D8.2 – 1st Technical diagram of EQIPD-DWH
Deliverable Report D8.5 – Data sharing procedures beyond EQIPD